Status:
RECRUITING
Uppsala Self-SCREENing of Heart Failure Study
Lead Sponsor:
Uppsala University
Conditions:
Heart Failure
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate whether a stepwise multimodal home-based screening strategy with rapid point-of-care testing can detect undiagnosed heart failure (HF) in high-risk pa...
Eligibility Criteria
Inclusion
- Age ≥40 years, and at least one of the following symptoms of HF, and at least two risk factors for HF:
- Symptoms
- Dyspnoea on exertion
- Dyspnoea at rest
- Orthopnoea
- Paroxysmal nocturnal dyspnoea
- Reduced exercise tolerance, increased time to recover after exercise
- Fatigue, tiredness
- Ankle swelling
- Risk factors
- Diabetes (type 1 or type 2)
- Coronary artery disease (myocardial infarction or coronary artery bypass grafting or percutaneous coronary intervention)
- Persistent or permanent atrial fibrillation (not paroxysmal atrial fibrillation)
- Previous ischemic or embolic stroke
- Peripheral arterial disease (previous surgical or percutaneous revascularisation)
- Chronic kidney disease
- Regular loop diuretic use (any dose at any dosing interval) for \>30 days
- COPD (diagnosis by respiratory physician, radiological emphysema or treatment with advocated COPD therapy)
Exclusion
- Previous diagnosis of HF
- Previous renal replacement therapy
- Inability to comply with study procedures or provide informed consent
Key Trial Info
Start Date :
February 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06940544
Start Date
February 1 2023
End Date
August 1 2026
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala Akademiska Hospital
Uppsala, Sweden